Target intelligence / Profile preview

Non-specific luminal toxins and macromolecules

Molecular classification
Other
01

Overview

Non-specific luminal toxins and macromolecules represent a broad pharmacological category of substances within the gastrointestinal tract that are targeted for neutralization or removal (DrugBank DB09278). This group includes a wide variety of exogenous materials, such as ingested poisons and pharmaceutical overdoses, as well as endogenous substances like bacterial toxins, inflammatory mediators, and metabolic byproducts (StatPearls NBK482294). Unlike classical drug targets such as receptors or enzymes, these entities are not specific biological molecules but rather a collection of pathogenic or toxic substrates. Drugs targeting these substances, primarily adsorbents like activated charcoal, function through physical sequestration rather than biochemical inhibition (PubChem CID 2723709). By binding these molecules within the gut lumen via Van der Waals forces and ionic interactions, these therapeutic agents prevent systemic absorption and local mucosal irritation. This mechanism is essential for the emergency treatment of acute intoxications and the management of various diarrheal diseases (WHO Model List of Essential Medicines). Consequently, the target is defined by the physical-chemical properties of the substances being adsorbed rather than a specific genetic or proteomic sequence.

Other names
Luminal toxinsIntestinal toxinsGastrointestinal macromoleculesAdsorbatesExogenous poisons
02

Mechanism of action

Physical adsorption and sequestration of toxins and macromolecules within the gastrointestinal lumen to prevent their absorption or local activity.

03

Biological functions

Other
04

Disease associations

InfectionOther
05

Safety considerations

Aspiration riskGastrointestinal obstructionReduced absorption of co-administered medicationsConstipation
06

Interacting drugs

Activated charcoal

4 more in the full profile.

07

Biomarkers

Serum toxin levelsStool consistencyFrequency of bowel movements

Beyond the preview

Go deeper on Non-specific luminal toxins and macromolecules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Non-specific luminal toxins and macromolecules.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call